Cargando…
Retraction Note: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192922/ https://www.ncbi.nlm.nih.gov/pubmed/32355227 http://dx.doi.org/10.1038/s41467-020-15721-y |
| _version_ | 1783528094158553088 |
|---|---|
| author | Janzen, D. M. Tiourin, E. Salehi, J. A. Paik, D. Y. Lu, J. Pellegrini, M. Memarzadeh, S. |
| author_facet | Janzen, D. M. Tiourin, E. Salehi, J. A. Paik, D. Y. Lu, J. Pellegrini, M. Memarzadeh, S. |
| author_sort | Janzen, D. M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7192922 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71929222020-05-05 Retraction Note: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer Janzen, D. M. Tiourin, E. Salehi, J. A. Paik, D. Y. Lu, J. Pellegrini, M. Memarzadeh, S. Nat Commun Retraction Note Nature Publishing Group UK 2020-04-30 /pmc/articles/PMC7192922/ /pubmed/32355227 http://dx.doi.org/10.1038/s41467-020-15721-y Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Retraction Note Janzen, D. M. Tiourin, E. Salehi, J. A. Paik, D. Y. Lu, J. Pellegrini, M. Memarzadeh, S. Retraction Note: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer |
| title | Retraction Note: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer |
| title_full | Retraction Note: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer |
| title_fullStr | Retraction Note: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer |
| title_full_unstemmed | Retraction Note: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer |
| title_short | Retraction Note: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer |
| title_sort | retraction note: an apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer |
| topic | Retraction Note |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192922/ https://www.ncbi.nlm.nih.gov/pubmed/32355227 http://dx.doi.org/10.1038/s41467-020-15721-y |
| work_keys_str_mv | AT janzendm retractionnoteanapoptosisenhancingdrugovercomesplatinumresistanceinatumourinitiatingsubpopulationofovariancancer AT tiourine retractionnoteanapoptosisenhancingdrugovercomesplatinumresistanceinatumourinitiatingsubpopulationofovariancancer AT salehija retractionnoteanapoptosisenhancingdrugovercomesplatinumresistanceinatumourinitiatingsubpopulationofovariancancer AT paikdy retractionnoteanapoptosisenhancingdrugovercomesplatinumresistanceinatumourinitiatingsubpopulationofovariancancer AT luj retractionnoteanapoptosisenhancingdrugovercomesplatinumresistanceinatumourinitiatingsubpopulationofovariancancer AT pellegrinim retractionnoteanapoptosisenhancingdrugovercomesplatinumresistanceinatumourinitiatingsubpopulationofovariancancer AT memarzadehs retractionnoteanapoptosisenhancingdrugovercomesplatinumresistanceinatumourinitiatingsubpopulationofovariancancer |